002826.SZ · 易明医药
China A-shares · RS rating 50 · As of 2026-10-14
| Price | 16.74 CNY |
|---|---|
| 1-day change | -0.9% |
| RS rating (overall / 1M / 3M / 12M) | 50 / 45 / 50 / 46 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 29 / 15 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -3.0% |
| Distance from 52-week high | +24.7% |
| Market cap (USD) | $504.2M |